Reported about 2 months ago
This article highlights two growth stocks, Pfizer and Realty Income, that present investment opportunities at discounted prices. Pfizer, while still down from past highs, shows solid profit growth, a robust pipeline from recent acquisitions, and a healthy dividend yield. Realty Income stands out as a consistent performer in the REIT sector, known for its reliable monthly dividends and impressive occupancy rates, making it an appealing option for investors seeking steady income.
Source: YAHOO